Altimmune , you better leave this sinking titanic Altimmune had a good run, but right now it's sinking faster than the Titanic. It breached both the 100 and 200 MA on H4 and is on its way down to around $5.
Key stats
Market capitalization
206.478MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.78USD
About Altimmune, Inc
ISIN
US02155H2004
Sector
Health Technology
Industry
Biotechnology
Website
altimmune.com
CEO
Vipin K. Garg
Headquarters
Gaithersburg
Employees
52
Founded
1997
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Long scalp ALTBased on its uptrend, rebound from support and a familiar chart pattern confirmed by my technical indicators, I expect at least half a percent in profits IF
ALT exceeds Friday's high of $20.94 during Monday's session.
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND fALT: Altimmune, Inc
2022-01-31 07:00:00
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
Altimmune Announces Positive Results From 12-week Phase 1 ClinicALT: Altimmune, Inc
2021-09-28 07:01:00
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers
Long | ALTNASDAQ:ALT
Possible Scenario: LONG
Evidence: Price Action,
TP1: 15.50$ to fill the gap
Call options, Strike 16$, 10/15/2021
Call options, Strike 18$, 10/15/2021
Call options, Strike 19$, 10/15/2021
*This is my idea and could be wrong 100%.
ALT Breakout to $16.00I am bullish on ALT due to confluence. Option Open Interest shows a wall at £12.00 and $16.00 . EMA 9/50/200 consolidating around 13.50-14.50 where the down trend line meets all 3. As well as the up trend line indicating a pressure point. MACD is giving a buy signal. Bollinger Bands and Donchian Ch
ALT Price Targets with Expected Resistance and SupportsLabeled are the price targets for the breakout uptrend.
The ascending stop loss would be used when each level has been used as support.
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0